Physica A: Statistical Mechanics and its ApplicationsBiophysicsPeer-reviewed journal article
Phase transitions may explain why SARS-CoV-2 spreads so fast and why new variants are spreading faster
Abstract
The novel coronavirus SARS CoV-2 responsible for the COVID-19 pandemic and SARS CoV-1 responsible for the SARS epidemic of 2002-2003 share an ancestor yet evolved to have much different transmissibility and global impact1. A previously developed thermodynamic model of protein conformations predicted that SARS CoV-2 is very close to a thermodynamic critical point, which makes it highly infectious but also easily displaced by a spike-based vaccine because there is a tradeoff between transmissibility and robustness2. The model identified a small cluster of four key mutations of SARS CoV-2 that promotes much stronger viral attachment and viral spreading. Here we apply the model to two new strains (B.1.1.7 and B.1.351)3 and predict, using no free parameters, how the new mutations can further enhance infectiousness.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- More or less deadly? A mathematical model that predicts SARS-CoV-2 evolutionary direction.
- Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants
Austin N. Spratt, Saathvik R. Kannan, … Kamal Singh·bioRxiv·Mar 24, 2021
- Transmission of mutated SARS-CoV-2 variants is favored by relatively prolonged infections due to delayed immunity
Katherine L. Owens, Pierce E. Radecki, … Daniel B. Reeves·bioRxiv·Sep 18, 2026
- Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
- Transition from infectivity and immune escape to pure escape as an evolutionary strategy during the COVID-19 pandemic.
Ben Kotzen, Sarah F. Gurev, … Jacob E. Lemieux·bioRxiv·Feb 27, 2026
- Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
B. Korber, W. Fischer, … Sheffield COVID-19 Genomics Group·bioRxiv·Apr 29, 2020